Loading provider…
Loading provider…
Internal Medicine Physician in Sacramento, CA
NPI: 1346340296Primary Practice Location
Douglas Young, M.D.,Inc.
3840 Watt Ave, Sacramento, CA
Primary Employer
Douglas Young, M.D.,Inc.
dyoungmd.com
HQ Phone
Get MD Douglas's Phone Numberphone_androidMobile
Get MD Douglas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1993 - 2027
OH State Medical License
1992 - 1994

Association of Clinical Research Professionals
Certified Principle Investigator
WashU Medicine
medicine.washu.edu
Medical School
Until 1990
University of Cincinnati Medical Center/College of Medicine
Residency • Internal Medicine
1990 - 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 139 | 340 |
| 2 | G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 111 | 111 |
| 3 | 99497Advance care planning by the physician or other qualified health care professional | 101 | 101 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 50 | 66 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 44 | 73 |
Efficacy of solifenacin for overactive bladder symptoms, symptom bother, and health-related quality of life in patients by duration of self-reported symptoms: a second...
Authors: Kelly Marie Gollar, Douglas G. Young, James Bailen, Weizhong He, Sergio Forero-Schwanhaeuser
Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: A US-based randomized, double-blind, placebo-controlled clinical trial
Authors: Kenneth H. Fife, Terri Warren, R. David Ferrera, Douglas G. Young, Scott E. Justus, Catherine K. Heitman, Scott Burroughs
Publication Date: 2006-10
Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: A US-based randomized, double-blind, placebo...
Authors: Kenneth H. Fife, Terri Warren, R. David Ferrera, Douglas G. Young, Scott E. Justus
Lead Sponsor: Helixmith Co., Ltd.
Intervention / Treatment: OTHER: placebo, BIOLOGICAL: Engensis (VM202)
Lead Sponsor: Helixmith Co., Ltd.
Intervention / Treatment: GENETIC: Long-Term Follow-Up of Patients who Received Engensis (VM202), DRUG: Long-Term Follow-Up of Patients who Received Placebo
Lead Sponsor: Neurovalens Ltd.
Collaborators: University College Dublin, CS Lifescience, Clinical Trial Mentors
Intervention / Treatment: BEHAVIORAL: Lifestyle modification, DEVICE: Vestal DM Active device, DEVICE: Vestal DM Sham device